Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

American Journal of Public Health, Vol. 77, Issue 11 1417-1426, Copyright © 1987 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (166)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinstein, M C
Right arrow Articles by Goldman, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinstein, M C
Right arrow Articles by Goldman, L
Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model.

M C Weinstein, P G Coxson, L W Williams, T M Pass, W B Stason and L Goldman

Institute for Health Research, Harvard School of Public Health, Boston, MA 02115.

A computer simulation model was developed to project the future mortality, morbidity, and cost of coronary heart disease (CHD) in the United States population. The model contains a demographic-epidemiologic (DE) submodel, which stimulates the distribution of coronary risk factors and the conditional incidence of CHD in a demographically evolving population; a "bridge" submodel, which determines the outcome of the initial CHD event; and a disease history (DH) submodel, which simulates subsequent events in persons with a previous CHD event. The user of the model may simulate the effects of interventions, either preventive (i.e., risk factor modification) or therapeutic, upon mortality, morbidity, and cost for up to a 30-year period. If there were no future changes in risk factors or the efficacy of therapies after 1980, baseline projections indicate that the aging of the population, and especially the maturation of the post-World War II baby-boom generation, would increase CHD prevalence and annual incidence, mortality, and costs by about 40-50 per cent by the year 2010. Unprecedented reductions in risk factors would be required to offset these demographic effects on the absolute incidence of CHD. The specific forecasts could be inaccurate, however, as a consequence of erroneous assumptions or misestimated baseline data, and the model awaits validation based on actual future data.




This article has been cited by other articles:


Home page
 AJPHHome page
J. Lightwood, K. Bibbins-Domingo, P. Coxson, Y. C. Wang, L. Williams, and L. Goldman
Forecasting the Future Economic Burden of Current Adolescent Overweight: An Estimate of the Coronary Heart Disease Policy Model
Am J Public Health, December 1, 2009; 99(12): 2230 - 2237.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
B. Stollenwerk, A. Gerber, K. W. Lauterbach, and U. Siebert
The German Coronary Artery Disease Risk Screening Model: Development, Validation, and Application of a Decision-Analytic Model for Coronary Artery Disease Prevention with Statins
Med Decis Making, September 1, 2009; 29(5): 619 - 633.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
M. J. Pletcher, L. Lazar, K. Bibbins-Domingo, A. Moran, N. Rodondi, P. Coxson, J. Lightwood, L. Williams, and L. Goldman
Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering
Ann Intern Med, February 17, 2009; 150(4): 243 - 254.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
K. Bibbins-Domingo, P. Coxson, M. J. Pletcher, J. Lightwood, and L. Goldman
Adolescent Overweight and Future Adult Coronary Heart Disease
N. Engl. J. Med., December 6, 2007; 357(23): 2371 - 2379.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
J. Karnon, A. Brennan, and R. Akehurst
A Critique and Impact Analysis of Decision Modeling Assumptions
Med Decis Making, August 1, 2007; 27(4): 491 - 499.
[Abstract] [PDF]

Home page
 J Pediatr PsycholHome page
W. E. Pelham, E. M. Foster, and J. A. Robb
The Economic Impact of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
J. Pediatr. Psychol., July 1, 2007; 32(6): 711 - 727.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
E. Huovinen, T. Harkanen, T. Martelin, S. Koskinen, and A. Aromaa
Predicting coronary heart disease mortality--assessing uncertainties in population forecasts and death probabilities by using Bayesian inference
Int. J. Epidemiol., October 1, 2006; 35(5): 1246 - 1252.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
S. M. Shechter, A. J. Schaefer, R. S. Braithwaite, and M. S. Roberts
Increasing the Efficiency of Monte Carlo Cohort Simulations with Variance Reduction Techniques
Med Decis Making, September 1, 2006; 26(5): 550 - 553.
[Abstract] [PDF]

Home page
 Epidemiol RevHome page
E. J. Dasbach, E. H. Elbasha, and R. P. Insinga
Mathematical Models for Predicting the Epidemiologic and Economic Impact of Vaccination against Human Papillomavirus Infection and Disease
Epidemiol. Rev., August 1, 2006; 28(1): 88 - 100.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
A Walker, J McMurray, S Stewart, W Berger, A D McMahon, H Dargie, K Fox, S Hillis, N J K Henderson, and I Ford
Economic evaluation of the impact of nicorandil in angina (IONA) trial.
Heart, May 1, 2006; 92(5): 619 - 624.
[Abstract] [Full Text] [PDF]

Home page
 Med Decis MakingHome page
R. L. Nijhuis, T. Stijnen, A. Peeters, J. C.M. Witteman, A. Hofman, and M. G. M. Hunink
Apparent and Internal Validity of a Monte Carlo-Markov Model for Cardiovascular Disease in a Cohort Follow-up Study
Med Decis Making, March 1, 2006; 26(2): 134 - 144.
[Abstract] [PDF]

Home page
 Med Decis MakingHome page
O. Alagoz, C. L. Bryce, S. Shechter, A. Schaefer, C.-C. H. Chang, D. C. Angus, and M. S. Roberts
Incorporating Biological Natural History in Simulation Models: Empirical Estimates of the Progression of End-Stage Liver Disease
Med Decis Making, November 1, 2005; 25(6): 620 - 632.
[Abstract] [PDF]

Home page
 Management ScienceHome page
J. E. Smith and R. L. Keeney
Your Money or Your Life: A Prescriptive Model for Health, Safety, and Consumption Decisions
Management Science, September 1, 2005; 51(9): 1309 - 1325.
[Abstract] [PDF]

Home page
 CirculationHome page
J. Critchley, J. Liu, D. Zhao, W. Wei, and S. Capewell
Explaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999
Circulation, September 7, 2004; 110(10): 1236 - 1244.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
H. D. Sesso, R. S. Chen, G. J. L'Italien, P. Lapuerta, W. C. Lee, and R. J. Glynn
Blood Pressure Lowering and Life Expectancy Based on a Markov Model of Cardiovascular Events
Hypertension, November 1, 2003; 42(5): 885 - 890.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S.D. Ramsey and S.D. Sullivan
The burden of illness and economic evaluation for COPD
Eur. Respir. J., June 1, 2003; 21(41_suppl): 29S - 35s.
[Abstract] [Full Text] [PDF]

Home page
 Stat Methods Med ResHome page
G Parmigiani
Measuring uncertainty in complex decision analysis models
Statistical Methods in Medical Research, December 1, 2002; 11(6): 513 - 537.
[Abstract] [PDF]

Home page
 Am J EpidemiolHome page
J. A. Salomon, M. C. Weinstein, J. K. Hammitt, and S. J. Goldie
Empirically Calibrated Model of Hepatitis C Virus Infection in the United States
Am. J. Epidemiol., October 15, 2002; 156(8): 761 - 773.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J.-M. Gaspoz, P. G. Coxson, P. A. Goldman, L. W. Williams, K. M. Kuntz, M.G. M. Hunink, and L. Goldman
Cost Effectiveness of Aspirin, Clopidogrel, or Both for Secondary Prevention of Coronary Heart Disease
N. Engl. J. Med., June 6, 2002; 346(23): 1800 - 1806.
[Abstract] [Full Text] [PDF]

Home page
 AJPHHome page
D. H. Taylor Jr, V. Hasselblad, S. J. Henley, M. J. Thun, and F. A. Sloan
Benefits of Smoking Cessation for Longevity
Am J Public Health, June 1, 2002; 92(6): 990 - 996.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
The CDC Diabetes Cost-effectiveness Group
Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes
JAMA, May 15, 2002; 287(19): 2542 - 2551.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
J.A. Critchley and S. Capewell
Why model coronary heart disease?
Eur. Heart J., January 2, 2002; 23(2): 110 - 116.
[Full Text] [PDF]

Home page
 CirculationHome page
D. J. Cohen, D. A. Taira, R. Berezin, D. A. Cox, M.-C. Morice, G. W. Stone, and C. L. Grines
Cost-Effectiveness of Coronary Stenting in Acute Myocardial Infarction: Results From the Stent Primary Angioplasty in Myocardial Infarction (Stent-PAMI) Trial
Circulation, December 18, 2001; 104(25): 3039 - 3045.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
L. Goldman, K. A. Phillips, P. Coxson, P. A. Goldman, L. Williams, M. G. M. Hunink, and M. C. Weinstein
The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1012 - 1017.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. L. Daviglus and J. Stamler
Major risk factors and coronary heart disease: much has been achieved but crucial challenges remain
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1018 - 1022.
[Full Text] [PDF]

Home page
 JNMHome page
L. J. Shaw, A. E. Iskandrian, R. Hachamovitch, G. Germano, H. C. Lewin, T. M. Bateman, and D. S. Berman
Evidence-Based Risk Assessment in Noninvasive Imaging
J. Nucl. Med., September 1, 2001; 42(9): 1424 - 1436.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. A. Tice, E. Ross, P. G. Coxson, I. Rosenberg, M. C. Weinstein, M. G. M. Hunink, P. A. Goldman, L. Williams, and L. Goldman
Cost-effectiveness of Vitamin Therapy to Lower Plasma Homocysteine Levels for the Prevention of Coronary Heart Disease: Effect of Grain Fortification and Beyond
JAMA, August 22, 2001; 286(8): 936 - 943.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
K. A. Phillips, M. G. Shlipak, P. Coxson, P. A. Heidenreich, M. G. M. Hunink, P. A. Goldman, L. W. Williams, M. C. Weinstein, and L. Goldman
Health and Economic Benefits of Increased {beta}-Blocker Use Following Myocardial Infarction
JAMA, December 6, 2000; 284(21): 2748 - 2754.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
L. A. Prosser, A. A. Stinnett, P. A. Goldman, L. W. Williams, M. G.M. Hunink, L. Goldman, and M. C. Weinstein
Cost-Effectiveness of Cholesterol-Lowering Therapies according to Selected Patient Characteristics
Ann Intern Med, May 16, 2000; 132(10): 769 - 779.
[Abstract] [Full Text] [PDF]

Home page
 Med Care Res RevHome page
G. T. Ray, F. Collin, T. Lieu, B. Fireman, C. J. Colby, C. P. Quesenberry, S. K. Van Den Eeden, and J. V. Selby
The Cost of Health Conditions in a Health Maintenance Organization
Med Care Res Rev, March 1, 2000; 57(1): 92 - 109.
[Abstract] [PDF]

Home page
 JAMAHome page
S. H. Woolf
The Need for Perspective in Evidence-Based Medicine
JAMA, December 22, 1999; 282(24): 2358 - 2365.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
K. M. Kuntz, J. Tsevat, M. C. Weinstein, and L. Goldman
Expert Panel vs Decision-Analysis Recommendations for Postdischarge Coronary Angiography After Myocardial Infarction
JAMA, December 15, 1999; 282(23): 2246 - 2251.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
L. Goldman, P. Coxson, M. G. M. Hunink, P. A. Goldman, A. N. A. Tosteson, M. Mittleman, L. Williams, and M. C. Weinstein
The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines
J. Am. Coll. Cardiol., September 1, 1999; 34(3): 768 - 776.
[Abstract] [Full Text] [PDF]

Home page
 Stat Methods Med ResHome page
A. L Hersh, W. C Black, and A. N. Tosteson
Estimating the population impact of an intervention: a decision-analytic approach
Statistical Methods in Medical Research, August 1, 1999; 8(4): 311 - 330.
[Abstract] [PDF]

Home page
 Med Decis MakingHome page
A. D. Paltiel, J. A. Scharfstein, G. R. Seage, E. Losina, S. J. Goldie, M. C. Weinstein, D. E. Craven, and K. A. Freedberg
A Monte Carlo Simulation of Advanced HIV Disease: Application to Prevention of CMV Infection
Med Decis Making, April 1, 1998; 18(2): S93 - S105.
[Abstract] [PDF]

Home page
 JAMAHome page
P. D. Rumm, J. D. Gunzenhauser, and M. R. Krauss
Factors Contributing to Declines in Cardiac Mortality
JAMA, June 4, 1997; 277(21): 1678 - 1678.
[Abstract] [PDF]

Home page
 JAMAHome page
M. G. M. Hunink, L. Goldman, A. N. A. Tosteson, M. A. Mittleman, P. A. Goldman, L. W. Williams, J. Tsevat, and M. C. Weinstein
The Recent Decline in Mortality From Coronary Heart Disease, 1980-1990: The Effect of Secular Trends in Risk Factors and Treatment
JAMA, February 19, 1997; 277(7): 535 - 542.
[Abstract] [PDF]

Home page
 CirculationHome page
A. N.A. Tosteson, M. C. Weinstein, M. G.M. Hunink, M. A. Mittleman, L. W. Williams, P. A. Goldman, and L. Goldman
Cost-Effectiveness of Populationwide Educational Approaches to Reduce Serum Cholesterol Levels
Circulation, January 7, 1997; 95(1): 24 - 30.
[Abstract] [Full Text]

Home page
 JAMAHome page
T. F. Brewer, S. J. Heymann, G. A. Colditz, M. E. Wilson, K. Auerbach, D. Kane, and H. V. Fineberg
Evaluation of Tuberculosis Control Policies Using Computer Simulation
JAMA, December 18, 1996; 276(23): 1898 - 1903.
[Abstract] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
D. C. H. Cheng, J. Karski, C. Peniston, B. Asokumar, G. Raveendran, J. Carroll, H. Nierenberg, S. Roger, D. Mickle, J. Tong, et al.
MORBIDITY OUTCOME IN EARLY VERSUS CONVENTIONAL TRACHEAL EXTUBATION AFTER CORONARY ARTERY BYPASS GRAFTING: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL
J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 755 - 764.
[Abstract] [Full Text]

Home page
 CirculationHome page
E. L. Eisenstein, D. B. Mark, and R. M. Califf
Importance of Cost and Quality of Life in Decisions About Routine Angiography After Acute Myocardial Infarction: The Role of Cost-effectiveness Models
Circulation, September 1, 1996; 94(5): 869 - 871.
[Full Text]

Home page
 CirculationHome page
K. M. Kuntz, J. Tsevat, L. Goldman, and M. C. Weinstein
Cost-effectiveness of Routine Coronary Angiography After Acute Myocardial Infarction
Circulation, September 1, 1996; 94(5): 957 - 965.
[Abstract] [Full Text]

Home page
 Med Decis MakingHome page
M. Johannesson, J. S. Pliskin, and M. C. Weinstein
Are Healthy-years Equivalents an Improvement over Quality-adjusted Life Years?
Med Decis Making, December 1, 1993; 13(4): 281 - 286.
[Abstract] [PDF]

Home page
 Med Decis MakingHome page
R. W. Klein, R. S. Dittus, S. D. Roberts, and J. R. Wilson
Simulation Modeling and Health-care Decision Making
Med Decis Making, December 1, 1993; 13(4): 347 - 354.
[PDF]

Home page
 JAMAHome page
W. S. Browner, J. Westenhouse, and J. A. Tice
What If Americans Ate Less Fat? A Quantitative Estimate of the Effect on Mortality
JAMA, June 26, 1991; 265(24): 3285 - 3291.
[Abstract] [PDF]

Home page
 JAMAHome page
L. Goldman, M. C. Weinstein, P. A. Goldman, and L. W. Williams
Cost-effectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart Disease
JAMA, March 6, 1991; 265(9): 1145 - 1151.
[Abstract] [PDF]

Home page
 JAMAHome page
J. T. Edelson, M. C. Weinstein, A. N. A. Tosteson, L. Williams, T. H. Lee, and L. Goldman
Long-term Cost-effectiveness of Various Initial Monotherapies for Mild to Moderate Hypertension
JAMA, January 19, 1990; 263(3): 407 - 413.
[Abstract] [PDF]

Home page
 Arch Intern MedHome page
N. M. Kaplan
The Deadly Quartet: Upper-Body Obesity, Glucose Intolerance, Hypertriglyceridemia, and Hypertension
Arch Intern Med, July 1, 1989; 149(7): 1514 - 1520.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Public Health Association